60 Degrees Pharmaceuticals, Inc. (SXTP) Financials

$1.27

south_east
-$0.09 (-6.62%)
Day's range
$1.26
Day's range
$1.39

SXTP Income statement / Annual

Last year (2023), 60 Degrees Pharmaceuticals, Inc.'s total revenue was $253,573.00, an increase of 13.60% from the previous year. In 2023, 60 Degrees Pharmaceuticals, Inc.'s net income was -$3.77 M. See 60 Degrees Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Operating Revenue $253,573.00 $223,208.00 $1.16 M $2.18 M
Cost of Revenue $474,550.00 $432,370.00 $850,742.00 $702,989.00
Gross Profit -$220,977.00 -$209,162.00 $309,598.00 $1.48 M
Gross Profit Ratio -0.87 -0.94 0.27 0.68
Research and Development Expenses $691,770.00 $237,561.00 $318,350.00 $438,576.00
General & Administrative Expenses $4.24 M $1.30 M $1.12 M $1.46 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $4.24 M $1.30 M $1.12 M $1.46 M
Other Expenses $0.00 -$43,238.00 $37,515.00 -$121.00
Operating Expenses $4.93 M $1.54 M $1.43 M $1.85 M
Cost And Expenses $5.41 M $1.97 M $2.28 M $2.55 M
Interest Income $0.00 $0.00 $0.00 $0.00
Interest Expense $2.29 M $3.99 M $3.17 M $2.68 M
Depreciation & Amortization $100,372.00 $78,786.00 $71,785.00 $27,865.00
EBITDA -$1.43 M -$2.11 M -$1.01 M -$341,169.00
EBITDA Ratio -5.63 -7.68 -0.87 -0.16
Operating Income Ratio -20.33 -7.84 -0.97 -0.19
Total Other Income/Expenses Net $1.34 M -$4.43 M -$3.14 M -$2.63 M
Income Before Tax -$3.81 M -$6.18 M -$4.26 M -$3.05 M
Income Before Tax Ratio -15.04 -27.68 -3.67 -1.4
Income Tax Expense $250.00 $500.00 $1,000.00 $1,000.00
Net Income -$3.77 M -$6.18 M -$4.25 M -$3.03 M
Net Income Ratio -14.85 -27.69 -3.66 -1.39
EPS -0.95 -1.07 -0.74 -0.52
EPS Diluted -0.95 -1.07 -0.74 -0.52
Weighted Average Shares Out $3.96 M $5.78 M $5.78 M $5.78 M
Weighted Average Shares Out Diluted $3.96 M $5.78 M $5.78 M $5.78 M
Link